Okay, let's tackle this question about the diagnostic test for pancreatic insufficiency. First, I need to recall what pancreatic insufficiency is. It's when the pancreas doesn't produce enough digestive enzymes, leading to malabsorption. The main symptom is steatorrhea, which is fatty, foul-smelling stools.

Now, the question is asking which test is used to diagnose this. The options aren't listed, but I can think about the common tests. The most specific one is the fecal elastase test. That's a non-invasive test where they check the level of elastase in the stool. Low levels indicate exocrine pancreatic insufficiency.

Other tests might include the fecal fat test, which measures the amount of fat in the stool over 72 hours. But that's more time-consuming and less commonly used. There's also the secretin stimulation test, which is invasive and involves endoscopy, so it's not first-line. The most common ones are fecal elastase and fecal fat.

Wait, the correct answer here is probably fecal elastase. Let me make sure. Fecal elastase is a reliable, non-invasive test. It's specific for pancreatic insufficiency. So if the options include that, that's the answer. The other options might be things like serum amylase, which isn't diagnostic for insufficiency. Or maybe endoscopic tests, which are more for other issues like cancer.

So the core concept is that fecal elastase is the key test. The wrong options would be other tests that aren't specific or aren't used for this condition. The clinical pearl is to remember that non-invasive tests like fecal elastase are preferred.

**Core Concept**
Pancreatic insufficiency is diagnosed by assessing pancreatic exocrine function, primarily through measuring enzyme levels in stool or pancreatic secretions. Fecal elastase-1 is a sensitive, non-invasive biomarker for exocrine pancreatic dysfunction.

**Why the Correct Answer is Right**
Fecal elastase-1 testing is the **gold standard** for diagnosing pancreatic insufficiency. Elastase-1 is a pancreatic enzyme excreted in stool; decreased levels (<200 μg/g) indicate impaired exocrine function. This test avoids the invasiveness of endoscopic methods and is preferred over 72-hour fecal fat quantification, which is cumbersome and less specific. **Why Each Wrong Option is Incorrect** **Option A:** Serum amylase/lipase are acute markers of pancreatitis, not chronic insufficiency. **Option B:** Stool fat quantification is outdated due to low reproducibility and patient non-compliance. **Option C:** Secretin stimulation test is invasive and reserved for complex cases (e.g., cystic fibrosis) where fecal elastase is inconclusive. **Option D:** Abdominal ultrasound lacks specificity for pancreatic insufficiency and is used to assess pancreatic morphology, not function. **Clinical Pearl / High-Yield Fact** Remember: **"Elastase in the stool, low means pancreatic trouble"**. Fecal elastase-1 is a high-yield exam topic—contrast it with serum markers (e.g., amylase/lipase) which are **not** diagnostic of chronic insufficiency. Always prioritize non-invasive

✓ Correct Answer: D. Faecal fat estimation